EORTC %2830885%29 randomized phase II study with recombinant…
EORTC %2830885%29 randomized phase II study with recombinant interferon-alpha and recombinant interferon-alpha and-gamma in patients with advanced renal cell carcinoma
Article, Chapter
Authors:
P.H.M. de Mulder
Publication:
Volume:71,
Page(s):371-375
Published:
1995
We were unable to find direct full text links for this item.